H19 gene overexpression in atypical multidrug-resistant cells associated with expression of a 95-kilodalton membrane glycoprotein

Cancer Research

Volumn 56, Issue 13, 1996, Pages 2904-2907

  Doyle, L Austin ^a   Yang, Weidong ^b   Rishi, Arun K ^b   Gao, Yongming ^b   Ross, Douglas D ^b  

^a UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; GLYCOPROTEIN; MEMBRANE PROTEIN;

ARTICLE; BREAST CARCINOMA; DATA BASE; DRUG RESISTANCE; GENE EXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BREAST NEOPLASMS; CLONING, MOLECULAR; DNA PROBES; DNA, NEOPLASM; DRUG RESISTANCE, MULTIPLE; GENE EXPRESSION; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; NEOPLASM PROTEINS; RNA, UNTRANSLATED; TUMOR CELLS, CULTURED;

EID: 0029980046     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Chen, Y-N., Mickley, L. A., Schwartz, A. M., Acton, E. M., Hwang, J., and Fojo, A. T. Characterization of Adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein. J. Biol. Chem., 265: 10073-10080, 1990.
2. Doyle, L A., Ross, D. D., Sridhara, R , Fojo, A. T , Kaufmann, S. H., Lee, E. J , and Schiffer, C. A. Expression of a 95 kDa membrane protein is associated with low daunorubicin accumulation in leukaemic blast cells. Br. J Cancer 71: 52-58, 1995.
3. Lee, J. S., Dickstein, B , and Bates, S. E. Reduced drug accumulation without P-glycoprotein (Pgp) expression in MCF-7 AdrVp cells. Proc. Am. Assoc. Cancer Res., 35: 2128, 1994
4. Doyle, L. A., Kaufmann, S. H., Fojo, A T , Bailey, C. L., and Gazdar, A. F. A novel 95 kilodalton membrane polypeptide associated with lung cancer drug resistance. Lung Cancer, 9: 317-326, 1993.
5. Doyle, L. A., Gao, Y., Yang, W., and Ross, D. D. Characterization of a 95 kilodalton membrane glycoprotein associated with multi-drug resistance. Int J. Cancer, 62: 593-598, 1995.
6. Gazdar, A. F., Steinberg, S. M., Russell, E. K., Linnoila, R. I., Oie, H K., Ghosh, B. C., Cotelingen, J. D., Johnson, B. E., Minna, J. D., and Ihde, D. C. Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer, a prospective clinical trial. J. Natl. Cancer Inst., 82: 117-124, 1990.
7. Marquardt, D., McCrone, S., and Center, M. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein. Cancer Res , 50: 1246-1430, 1990.
8. Doyle, L. A., Ross, D. D , Ordonez, J. V., Yang, W., Tong, Y , Belani, C. P , and Gutheil, J. C. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. Br J Cancer, 72: 535-542, 1995
9. Ross, D. D., Doyle, L. A., Schiffer, C. A., Lee, E. J., Grant, C. E., Cole, S. P C., Deeley, R. G , Yang, W , and Tong, Y Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients. Leukemia (Baltimore), 10, 48-55, 1996
10. Brannan, C. I , Dees, E. C., Ingram, R. S., and Tilghman, S. M. The product of the H19 gene may function as an RNA. Mol. Cell. Biol , 10: 28-36, 1990
11. Kondo, M., Suzuki, H., Ueda, R., Osada, H., Takagi, K., Toshitada, T., and Takahashi, T. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene, 10: 1193-1198, 1995.
12. Pachnis, V., Belayew, A., and Tilghman, S. M A locus unlinked to α-fetoprotein under the control of the murine raf/Rif genes. Proc. Natl. Acad. Sci. USA, 81: 5523-5527, 1984.
13. Pachnis, V., Brannan, C. I., and Tilghman, S. M. The structure and expression of a novel gene activated by early mouse embryogenesis. EMBO J., 7: 673-681, 1988.
14. Li, E , Beard, C., and Jaenisch, R. Role for DNA methylation in genomic imprinting. Nature (Lond.), 366: 362-365, 1993.
15. Bartolomei, M. S., Webber, A. L., Brunkow, M E., and Tilghman, S. M. Epigenetic mechanisms underlying the imprinting of the mouse H19 gene. Genes Dev , 7: 1663-1673, 1993.
16. Zemel, S., Bartolomei, M. S., and Tilghman, S. M. Physical linkage of two mammalian imprinted genes, H19 and insulin-like growth factor 2. Nat. Genet., 2: 61-65, 1992.
17. Brunkow, M. E., and Tilghman, S. M. Ectopic expression of the H19 gene in mice causes prenatal lethality. Genes Dev., 5, 1092-1101, 1991.
18. Leibovitch, M. P , Solhonne, B , Guillier, M., Verelle, P. and Leibovitch, S. A. Direct relationship between the expression of tumor suppressor H19 mRNA and c-mos proto-oncogene during myogenesis. Oncogene, 10: 251-260, 1995
19. Zhang, Y., Shields, T , Crenshaw, T., Hao, Y., Moulton, T., and Tycko, B. Imprinting of human H19, allele-specific CpG methylation, loss of the active allele in Wilms tumor and potential for somatic allele switching. Am. J. Hum. Genet., 53: 113-124, 1993.
20. Hao, Y., Crenshaw, T., Moulton, T , Newcomb, E., and Tycko, B. Tumour-suppressor activity of H19 RNA. Nature (Lond.), 365: 764-767, 1993
21. Biedler, J L., Riehm, H., Peterson, R. H., and Spengler, B A Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells J. Natl. Cancer Inst., 55: 671-680, 1975.
22. Kim, D. K., Zhang, L., Dzau, V. J., and Pratt, R. E. H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury. J. Clin. Invest., 93: 355-360, 1994.